To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Teresa Neumann/News Release : Jan 5, 2011  PR Newswire/Veridex

"There's a lot of potential here, and that's why there's a lot of excitement."

(Raritan, NJ)—Several news agencies this week have reported on an AP story about a "revolutionary" blood test that can spot a single cancer cell among millions of healthy ones. Since four large cancer centers will be using it in studies, and Johnson & Johnson has decided to bring it to the market, it signals great hope for early detection of the disease.

Notes excerpts from a PR Newswire release about the test, coined the CellSearch system: Measuring the change in circulating tumor cell (CTC) count can accurately predict the prognosis and survival in patients with metastatic breast cancer (MBC), according to a newly published report in the July 10, 2010 issue of the Journal of Clinical Oncology. The CellSearch(R) System is the first 510(k) diagnostic test used to automate the capture and detection of CTCs, tumor cells that have detached from solid tumors and entered the patient's blood. (Photo by: Griszka Niewiadomski)

"Measuring CTCs in metastatic breast cancer patients provides oncologists with an additional tool to help us better monitor patient outcomes," said one of the lead authors, Dr. Massimo Cristofanilli, associate professor in the Department of Breast Medical Oncology at The University of Texas M. D. Anderson Cancer Center. "The CellSearch(R) CTC test provides an early indication about patients' disease progression and overall survival."

CTCs and FDG-PET/CT are two of the most promising new tools for therapeutic monitoring in patients with MBC. The number of CTCs identified in patients with MBC is related to patient prognosis; a high number of CTCs at any time during treatment is associated with poor prognosis.

The CellSearch(R) test works by using antibodies that are joined to microscopic iron particles, called ferrofluid. These antibody/ferrofluid combinations attach very specifically to CTCs. Powerful magnets then draw the CTCs out of the blood sample and they are then stained with additional bio-molecules and chemicals so that they can be positively identified as CTCs.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Thanksgiving: The Quintessential American Holiday

Mamdani Could Threaten Future of Pregnancy Care Centers, Pro-Life CEO Warns

Texas: Strongman Games World Championship Disqualifies Winner, Strips Him of 'Women's Open Title' Victory after Discovering He's Biologically Male

Parents Sue School District after 11-Year-Old Girl Was Forced to Share Bed With 'Transgender' Boy

Department of War Says Senator Kelly Faces Possible Court-Martial for 'Seditious' Video

Chicago Train Burning Shows How Too Much Leniency to the Guilty Is Cruelty to the Innocent

FDA's Makary: Fauci Orchestrated 'Massive Cover-Up' of COVID Origin

2 National Guard Members Shot in 'Targeted Attack' in Washington DC; Suspect Is in Custody

Remembering 'A Charlie Brown Thanksgiving'

Exposed: Soros Family Has Been Working With the US State Department for 50 Years, Wikileaks Shows

Bishops Vote to Prohibit Trans Surgeries and Hormone Treatment in Catholic Hospitals

Do No Harm Survey Shows Rank-and-File Doctors Oppose DEI in Healthcare

Federal Report Exposes Sacramento's Failure: AAP, AMA, WPATH Lied and Lawmakers Let Children Pay the Price

FBI's Patel and Bongino Share Details of Op that Stopped Huge Halloween Islamic Terror Plot: 'A Lot of People Would've Died'

President Trump Designates Muslim Brotherhood as a Foreign Terrorist Organization

Same Old Tricks: Big Tech News 'Aggregators' Suppress Dem Scandals in Lead-Up to Elections

Maryland School Board Resists State’s Attempt to Override Removal of Explicit LGBT Book

All Living Israeli Hostages Now Home, Embraced by Medical Staff and Loving Communities, Yet Facing Long Recovery

Chicago public schools blow millions on travel expenses while students can't read at grade level

'That doesn't exist': Doge reportedly quietly disbanded ahead of schedule

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor